Conclusions
In this multicentric study, individuals affected by MetS when compared
with no-MetS undergoing heart valve surgery experienced more
post-operative complications, including prolonged post-operative LOS,
with mortality rate significant higher in the MVS group.
In the TAVR cohort, post-operative complications and mortality rate did
not differ between patients with and without MetS, however overall LOS
was longer in the MetS group.
This data supports the need for further investigation for both risk
definition and reduction in patients with MetS, particularly in the
context of surgical heart valve surgical intervention.